[
    [
        {
            "time": "",
            "original_text": "大参林（603233.SH）：拟与关联方共同增资天宸健康 孵化探索互联网医疗相关业务",
            "features": {
                "keywords": [
                    "大参林",
                    "增资",
                    "天宸健康",
                    "互联网医疗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "互联网医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "大参林（603233.SH）：拟与关联方共同增资天宸健康 孵化探索互联网医疗相关业务",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "大参林：拟转让全资子公司广东康益百、大参林医疗健康100%股权 资产异常",
            "features": {
                "keywords": [
                    "大参林",
                    "转让",
                    "全资子公司",
                    "广东康益百",
                    "医疗健康"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "大参林：拟转让全资子公司广东康益百、大参林医疗健康100%股权 资产异常",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06",
            "original_text": "医药行业2021年6月投资月报：6月仍然是较好的窗口期 两条思路配置医药",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资月报",
                    "窗口期",
                    "配置思路"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2021年6月投资月报：6月仍然是较好的窗口期 两条思路配置医药",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]